Download PDF
J Neurol Surg B Skull Base 2021; 82(S 03): e15-e21
DOI: 10.1055/s-0040-1701222
Original Article

Initial Observation among Patients with Vestibular Schwannoma

Henry Ruiz-Garcia
1   Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, United States
,
Jennifer Peterson
1   Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, United States
2   Department of Neurological Surgery, Mayo Clinic, Jacksonville, Florida, United States
,
Janet Leon
1   Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, United States
,
Timothy Malouff
1   Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, United States
,
Laura Vallow
1   Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, United States
,
Larry Lundy
3   Department of Otolaryngology, Mayo Clinic, Jacksonville, Florida, United States
,
Kaisorn L. Chaichana
2   Department of Neurological Surgery, Mayo Clinic, Jacksonville, Florida, United States
,
Prasanna Vibhute
4   Department of Radiology, Mayo Clinic, Jacksonville, Florida, United States
,
Daniel M. Trifiletti 
1   Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, United States
2   Department of Neurological Surgery, Mayo Clinic, Jacksonville, Florida, United States
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Introduction Vestibular schwannomas (VS) are slow growing tumors. Although there are a wide variety of available treatment options, these tumors are often initially observed. We aimed to establish the presenting symptoms and outcomes of patients treated with initial observation at our institution.

Methods The medical records of patients with radiographically diagnosed VS were reviewed from 1989 to 2018. Actuarial estimates of radiographic tumor control and freedom of local therapy were calculated and compared using Cox regression analyses.

Results A total of 360 patients were diagnosed with VS at our institution from 1989 through 2018 with a median age of 59.9 years. After radiographic diagnosis, 243 patients (67.5%) opted for initial observation. Local control at 1, 5, and 10 years was 91, 67, and 58%, respectively. On multivariable analysis, factors associated with shorter time to radiographic tumor progression included younger patient age (p = 0.016) and tumors with an extracanalicular component (p = 0.032). Regarding time until definitive treatment only larger baseline American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) tumor size predicted for earlier initiation of therapy (p < 0.001), although this was restricted to tumors with an extracanalicular component (p = 0.004), as opposed to purely internal auditory canal tumors (p = 0.839).

Conclusion Many patients who were initially observed continued to have satisfactory local control rates at 10 years. In patients with extracanalicular tumors, larger AAO-HNS tumor measurements were associated with earlier radiographic tumor progression and shorter time to local therapy, with 7 mm serving as a potential threshold value for extracanalicular tumors. Younger patients and tumors with primarily an extracanalicular portion may warrant closer observation.

Keywords

acoustic neuroma - gamma knife - cyberknife - SRS - surgery - conservative


Publication History

Received: 02 May 2019

Accepted: 02 December 2019

Article published online:
24 January 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Rosahl S. Acoustic neuroma: treatment or observation?. Dtsch Arztebl Int 2009; 106 (30) 505-506
    PubMedGoogle Scholar
  • 2 Rosenberg SI. Natural history of acoustic neuromas. Laryngoscope 2000; 110 (04) 497-508
    CrossrefPubMedGoogle Scholar
  • 3 Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC. Otolaryngol Head Neck Surg 1995; 113 (03) 179-180
    CrossrefPubMedGoogle Scholar
  • 4 Stangerup SE, Caye-Thomasen P, Tos M, Thomsen J. The natural history of vestibular schwannoma. Otol Neurotol 2006; 27 (04) 547-552
    CrossrefPubMedGoogle Scholar
  • 5 Fayad JN, Semaan MT, Lin J, Berliner KI, Brackmann DE. Conservative management of vestibular schwannoma: expectations based on the length of the observation period. Otol Neurotol 2014; 35 (07) 1258-1265
    CrossrefPubMedGoogle Scholar
  • 6 Chou KN, Tsai BH, Huang WY, Hueng DY. Morbidity in vestibular schwannoma surgery. J Neurosurg 2014; 120 (03) 785-786
    CrossrefPubMedGoogle Scholar
  • 7 Persson O, Bartek Jr J, Shalom NB, Wangerid T, Jakola AS, Förander P. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review. Acta Neurochir (Wien) 2017; 159 (06) 1013-1021
    CrossrefPubMedGoogle Scholar
  • 8 Sughrue ME, Kane AJ, Kaur R. et al. A prospective study of hearing preservation in untreated vestibular schwannomas. J Neurosurg 2011; 114 (02) 381-385
    CrossrefPubMedGoogle Scholar
  • 9 Régis J, Carron R, Park MC. et al. Wait-and-see strategy compared with proactive Gamma Knife surgery in patients with intracanalicular vestibular schwannomas. J Neurosurg 2010; 113 (Suppl): 105-111
    Google Scholar
  • 10 González-Orús Álvarez-Morujo RJ, Alvarez-Palacios I, Martin-Oviedo C, Scola-Yurrita B, Arístegui-Ruiz MA. Conservative management of vestibular schwannoma. Acta Otorrinolaringol Esp 2014; 65 (05) 275-282
    CrossrefPubMedGoogle Scholar
  • 11 Valvassori GE, Shannon M. Natural history of acoustic neuromas. Skull Base Surg 1991; 1 (03) 165-167
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Al Sanosi A, Fagan PA, Biggs ND. Conservative management of acoustic neuroma. Skull Base 2006; 16 (02) 95-100
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Selesnick SH, Johnson G. Radiologic surveillance of acoustic neuromas. Am J Otol 1998; 19 (06) 846-849
    PubMedGoogle Scholar
  • 14 Deberge S, Meyer A, Le Pabic E, Peigne L, Morandi X, Godey B. Quality of life in the management of small vestibular schwannomas: observation, radiotherapy and microsurgery. Clin Otolaryngol 2018; 43 (06) 1478-1486
    CrossrefPubMedGoogle Scholar
  • 15 Hirvonen T, Pyykkö I, Juhola M, Aalto H. High frequency deficit of the vestibular system after acoustic neurinoma surgery. Acta Otolaryngol Suppl 1995; 520 (Pt 1): 16-18
    CrossrefPubMedGoogle Scholar
  • 16 Hunter JB, Dowling EM, Lohse CM. et al. Hearing outcomes in conservatively managed vestibular schwannoma patients with serviceable hearing. Otol Neurotol 2018; 39 (08) e704-e711
    CrossrefPubMedGoogle Scholar
  • 17 Prasad SC, Patnaik U, Grinblat G. et al. Decision making in the wait-and-scan approach for vestibular schwannomas: is there a price to pay in terms of hearing, facial nerve, and overall outcomes?. Neurosurgery 2018; 83 (05) 858-870
    CrossrefPubMedGoogle Scholar
  • 18 Lees KA, Tombers NM, Link MJ. et al. Natural history of sporadic vestibular schwannoma: a volumetric study of tumor growth. Otolaryngol Head Neck Surg 2018; 159 (03) 535-542
    CrossrefPubMedGoogle Scholar